PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Propanc Biopharma, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$0.32−0.03 (-7.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Propanc Biopharma from other investors
No posts about PPCB yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.